Living with Type 1 diabetes is a numbers game. There’s not a moment in the day free from the burden of tracking your blood ...

There has been a rumor that Apple is working on a glucose monitoring solution for the Apple watch. [Harley] decided not to wait and managed to interface an Abbot FreeStyle Libre sensor with the ...

DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Gross margin reflects inventory damage. Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024. Alphatec (ATEC) witnessed a ...

Strong Product Demand: We are upbeat about DexCom's continued strength in CGM products. DexCom demonstrated strong product demand in third-quarter 2024, highlighted by record new patient starts in ...

SAN FRANCISCO—After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have diabetes, Dexcom said it expects to see more than $4.03 ...

DexCom (NASDAQ:DXCM) shares, currently trading at $85.48 with a market capitalization of $33.38 billion, maintained their ...

Dexcom’s focus on expanding continuous glucose monitoring access, rolling out new products like the Stelo, and its plans for international growth suggest promising opportunities for future ...

"Dexcom made key strategic investments in 2024," said CEO Kevin Sayer, adding the company plans to build on these investments in 2025 by advocating for greater CGM access globally. The company is ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

The job for Abbott, and competitors like Dexcom and Medtronic, is now to build awareness and make a business case for payers to cover these products, he said. Globally, that means CGM makers will ...